Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

They could also receive as much as an additional $3 per share from the future monetization of Walgreens' debt and equity interests in its VillageMD clinic business. The buyout, which will take the ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion buyout by New York-based private equity firm Sycamore Partners Management during ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Walgreens shareholders will receive $11.45 per share from Sycamore Partners per the terms of the deal first announced in March, ... The buyout, which will take the drugstore chain private, ...

Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain's $10 billion acquisition by private equity firm Sycamore. It is a rough era for national pharmacy chains like ...

Walgreens shareholders approve $10 billion private equity buyout By The Associated Press July 11, 2025 FILE - A Walgreens store in Bradenton, Fla., is shown on Feb. 9, 2024.

Walgreens Boots Alliance shareholders gave the thumbs-up to the company's private-equity buyout by Sycamore Partners, with about 96% of votes cast approving the sale, the Deerfield-based retail ...